Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Eyenovia Announces Pricing of $5M Registered Direct Offering
-
Soleno Therapeutics Announces Submission of New Drug Application to the U.S. FDA for DCCR (Diazoxide Choline) Extended-Release Tablets for the Treatment of Prader-Willi Syndrome
-
Minerals Technologies Announces Second Quarter 2024 Conference Call
-
Talisker Announces Results of Annual General Meeting of Shareholders
-
Genius Group Announces New Equity Research Report from Diamond Equity Research
-
International Land Alliance Announces Year End 2023 Results
-
Futureverse and Animoca Brands form strategic partnership with mutual investment to fuel technology stack and token ecosystem growth
-
Inovalon and MEDITECH Collaborate to Transform and Optimize Revenue Cycle
-
Elara Caring Expands Services with Acquisition of Caregivers Home Health
-
Bitdeer Expands Power Capacity Pipeline to 2.5 GW with 570 MW Strategic Partnership with Monroe County Port Authority in Ohio
-
Ragnarok: Rebirth Official Launching in Southeast Asia on June 27, 2024
-
Change in number of shares and votes in Hexatronic
-
GRANITESHARES SURPASSES $7 BILLION AUM AS NVIDIA REBOUNDS
-
Clearmind Medicine Granted Patent Approval in Hong Kong for its Binge Behaviors Treatment
-
Invesco Ltd: Form 8.3 - DS Smith PLC
-
Invesco Ltd: Form 8.3 - Alpha Financial Markets Consulting PLC
-
Earth Alive Announces Election of Directors
-
DeFi Technologies’ Subsidiary Valour Inc. Debuts World's First CORE ETP and Expands World’s First Hedera ETP to Spotlight Stock Market
-
Intermap Technologies Announces Voting Results of the Annual Meeting of Shareholders
-
Old Dominion University Launches Mobile Credentials with CBORD and Allegion
-
Total Voting Rights
-
Troilus Files NI 43-101 Technical Report for the Troilus Project’s Feasibility Study
-
Subsea 7 S.A. cancels treasury shares
-
Orchard Therapeutics Celebrates Global Progress toward Advancing Newborn Screening for MLD on International Neonatal Screening Day
-
CryptoSafe Unveils Safe Pay: A Game-Changer in Cryptocurrency Payment Solutions
-
Iovance Biotherapeutics Submits Marketing Authorization Application to European Medicines Agency for Lifileucel in Advanced Melanoma
-
OTC Markets Group Welcomes Golden Metal Resources PLC to OTCQX
-
Eliem Therapeutics Announces its Addition to the Russell 2000® and Russell 3000® Indexes
-
Asset Entities Inc. Announces Reverse Stock Split to Regain Compliance with Nasdaq’s Minimum Bid Price
-
Plug to Receive Federal Clean Hydrogen Production Tax Credit at Georgia Hydrogen Facility
-
OTC Markets Group Welcomes Endo, Inc. to OTCQX
-
Verve Therapeutics Announces Appointment of Nia Tatsis, Ph.D., and Jodie Morrison to its Board of Directors
-
23andMe And Nightingale Health Announce Strategic Collaboration To Pilot Blood Biomarker Panel
-
Amwell Announces Reverse Stock Split
-
Odronextamab Recommended for EU Approval by the CHMP to Treat Relapsed/Refractory Follicular Lymphoma and Diffuse Large B-cell Lymphoma
-
Esperion Announces Monetization of European Royalties and Concurrent Payoff and Termination of Existing Revenue Interest Facility
-
RAIR Technologies Empowers Developers to Build Web3 Applications through India’s Largest Hackathon
-
Crown Crafts Announces Financial Results for Fourth Quarter and Full Year Fiscal 2024
-
AB Science provides an update on the application for conditional marketing authorisation of masitinib in ALS
-
Apellis Plans to Seek Re-Examination Following Negative CHMP Opinion for Pegcetacoplan for Geographic Atrophy (GA) in the EU
-
OKX Marketplace and Layer3 to Give Away 50,000 Polygon-Based 'Layer3 x OKX Genesis' NFTs
-
OKX Wallet Now Integrated with DeltaTrade
-
Tri Pointe Homes, Inc. Announces Second Quarter 2024 Earnings Release and Conference Call Date
-
ARS Pharmaceuticals Announces EURneffy (adrenaline nasal spray) Recommended for Approval by CHMP for Emergency Treatment of Allergic Reactions (anaphylaxis)
-
OKX Wallet Now Integrated with Mitosis, an Ecosystem-Owned Liquidity Layer 1 Blockchain
-
Roche’s Vabysmo gets CHMP recommendation for third indication retinal vein occlusion (RVO)
-
Issue of Equity and Total Voting Rights
-
Resolutions of Valoe’s Annual General Meeting, Decision on a Follow-up Meeting, and Organising of the Board of Directors
-
Orchard Therapeutics Celebrates Global Progress toward Advancing Newborn Screening for MLD on International Neonatal Screening Day
-
Man Group PLC : Form 8.3 - International Paper Company
